In Episode 4 of The Skinny on the Shot, Dr. Michelle Gilliatte explores what GLP-1 medications are doing beyond weight loss. From protecting your heart and kidneys to improving liver health, reducing inflammation, and even showing promise in areas like addiction and longevity, these medications are changing the way we think about metabolic health.

But which benefits are backed by strong clinical evidence, and which are still emerging? Dr. Gilliatte breaks down the latest research, explains the difference between the headlines and the actual data, and helps you understand what these medications may really be doing inside the body.

In this episode of The Skinny on the Shot, Dr. Michelle Gilliatte breaks down how GLP-1 medications actually work, beyond the "they kill your appetite" explanation most people give.

You'll learn what GLP-1 really is (a hormone your body already makes), the four jobs it does, and why it lowers blood sugar without the dangerous lows of older drugs. Dr. G uses a simple delivery-driver analogy to explain insulin resistance, why adding more insulin was never the fix, and how clearing visceral fat is what actually solves the problem. She also introduces your body's full crew of hunger hormones, ghrelin, CCK, GLP-1, and PYY, and explains why the system breaks down in the first place.

The big takeaway: these medications aren't a foreign chemical hijacking your body. They're a louder copy of a signal you've been making your whole life, turning up a system that got turned down. This reframe changes the conversation from willpower to biology.

Whether you're on a GLP-1, considering one, or just want to be the person at dinner who can explain it, this episode gives you the foundation.

Welcome to Episode 1 of The Skinny on the Shot , a series breaking down the science, history, and future of GLP-1 medications.

In this first episode, Dr. G takes a closer look at where GLP-1s began, why early versions failed to gain traction, and what changed to make these medications one of the biggest shifts in modern healthcare. From weight loss and metabolic health to the growing cultural conversation surrounding these treatments, we explore what the rise of GLP-1 medications could mean for the future of wellness and medicine.

Whether you’re curious about the science behind the shot or trying to separate hype from facts, this episode is your starting point.

Everyone's talking about "the shot" — semaglutide, tirzepatide, Ozempic, Wegovy, Mounjaro, Zepbound. The miracle stories and the horror stories dominate social media, but somewhere in between is the actual medicine.

Skinny on the Shot is hosted by Dr. Michelle Gilliatte, physician and owner of SomaVie Wellness Center & Med Spa in Indiana, where she runs a medically supervised weight management program. The podcast cuts through the noise with the evidence-based, doctor's-office version of the GLP-1 conversation — no jargon, no hype, no agenda.

Upcoming episodes will cover how these medications actually work, who they're for and who they aren't, what the side effects really look like, the difference between compounded and brand-name formulations, how to protect muscle mass and facial volume, what happens when patients stop, and the questions that come up most often in clinical practice.

This introductory episode lays the groundwork: who Dr. Gilliatte is, why she started the show, what listeners can expect from the series, and the one thing every patient should understand before their first injection.

In this episode of The Vital Link, Dr. Gilliatte tackles one of the most common and emotionally charged questions she has received in women’s health: Can you safely use hormone replacement therapy if you have a family history of breast cancer?

For decades, women have been told that a family history is a hard stop when it comes to HRT. But is that actually supported by the science?

Dr. Gilliatte breaks down the latest research, including insights from the Women’s Health Initiative and new data presented in late 2025 on BRCA gene mutations. She explains the difference between perceived risk and actual risk, challenges the myth of an “additive effect,” and puts HRT-related risks into real-world perspective by comparing them to everyday lifestyle factors.

If you are new here, don't forget to follow so you never miss a discussion! For more information about SomaVie, check out our website: somaviewellness.com

Follow SomaVie Wellness on Social

Instagram: @somaviewellness

*

Tik Tok: @somaviewellness

*

Facebook: @somaviewellness

*

Linktree: @somaviewellness